Table 1 Characteristics of 100 patients with AML
Variable at diagnosis | APL patients (n = 40) | Non-APL patients (n = 60) |
|---|---|---|
N (%) | N (%) | |
Gender | ||
 Female | 25 (62.5) | 30 (50) |
 Male | 15 (37.5) | 30 (50) |
Age | ||
  < 50 | 30 (75.0) | 35 (58.3) |
  ≥ 50 | 10 (25.0) | 25 (41.7) |
Leukocyte counts, ×109/L | ||
  < 10 | 35 (87.5) | 45 (75.0) |
  ≥ 10 | 5 (12.5) | 15 (25.0) |
Risk group | ||
 Low/intermediate | 35 (87.5) | – |
 High | 5 (12.5) | – |
Treatment | ||
 ATO + ATRA | 38 (95.0) | – |
 Cytarabine + ATRA | 2 (5.0) | – |